| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00000478-198210000-00007 |
| P698 | PubMed publication ID | 7180965 |
| P2093 | author name string | C Limas | |
| L C Lasky | |||
| S A Fuhrman | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 655-663 | |
| P577 | publication date | 1982-10-01 | |
| P1433 | published in | The American Journal of Surgical Pathology | Q7713508 |
| P1476 | title | Prognostic significance of morphologic parameters in renal cell carcinoma | |
| P478 | volume | 6 |
| Q38411777 | 18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas |
| Q35394714 | 3D texture analysis in renal cell carcinoma tissue image grading |
| Q50913242 | A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies. |
| Q60301871 | A Deep Learning-Based Radiomics Model for Differentiating Benign and Malignant Renal Tumors |
| Q50910295 | A French national epidemiologic survey on renal cell carcinoma. Oncology Committee of the Association Française d'Urologie. |
| Q41948910 | A case of both clear and papillary renal cell carcinomas in the left kidney |
| Q42686254 | A comparison of pathologic outcomes of matched robotic and open partial nephrectomies |
| Q47791781 | A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas |
| Q88221108 | A novel marker ADAM17 for clear cell renal cell carcinomas: implication for patients' prognosis |
| Q52701381 | A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma. |
| Q73614042 | A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage |
| Q38966703 | A prospective, multicenter analysis of pseudocapsule characteristics: Do all stages of renal cell carcinoma have complete pseudocapsules? |
| Q43080869 | A rare case of synchronous renal cell carcinoma of the bladder presenting with gross hematuria. |
| Q36287414 | A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma |
| Q50072522 | A useful method for assessing differences of compensatory hypertrophy in the contralateral kidney before and after radical nephrectomy in patients with renal cell carcinoma: ellipsoid formula on computed tomography |
| Q37089505 | Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC |
| Q37401553 | Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma |
| Q30316394 | Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis |
| Q53183600 | Accuracy of multi-detector computed tomography (MDCT) in staging of renal cell carcinoma (RCC): analysis of risk factors for mis-staging and its impact on surgical intervention. |
| Q58734464 | Accurate Risk Assessment of Patients with Pathologic T3aN0M0 Renal Cell Carcinoma |
| Q35811828 | Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathologic implications of RNA content |
| Q84069164 | Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma |
| Q92133007 | Adipophilin expression in cutaneous malignant melanoma is associated with high proliferation and poor clinical prognosis |
| Q36713532 | Adjuvant therapy for high-risk renal cell carcinoma patients |
| Q35835613 | Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma |
| Q38318638 | Adrenocortical growth and cancer |
| Q123351242 | Advanced in vitro models for renal cell carcinoma therapy design |
| Q37507522 | Advances and controversies in grading and staging of renal cell carcinoma |
| Q35757963 | Advances of multidetector computed tomography in the characterization and staging of renal cell carcinoma |
| Q86425425 | Age--an independent prognostic factor of clinical outcome in renal malignancies: results of a large study over two decades |
| Q44404683 | Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma. |
| Q73336879 | Aldosterone-producing adrenocortical adenoma in childhood: a case report |
| Q35782701 | Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients |
| Q55363371 | Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers. |
| Q35974244 | Alteration of ASIC1 expression in clear cell renal cell carcinoma |
| Q36584397 | Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas |
| Q48624575 | Alterations of ubiquitylation and sumoylation in conventional renal cell carcinomas after the Chernobyl accident: a comparison with Spanish cases |
| Q64893429 | Altered Expression of DDR1 in Clear Cell Renal Cell Carcinoma Correlates With miR-199a/b-5p and Patients' Outcome. |
| Q33755267 | Altered glutamyl-aminopeptidase activity and expression in renal neoplasms. |
| Q31811713 | Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma |
| Q38467844 | Altered metabolic pathways in clear cell renal cell carcinoma: A meta-analysis and validation study focused on the deregulated genes and their associated networks |
| Q42147337 | Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompati |
| Q39801447 | American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy |
| Q60949867 | An Integrated Score and Nomogram Combining Clinical and Immunohistochemistry Factors to Predict High ISUP Grade Clear Cell Renal Cell Carcinoma |
| Q43717720 | An immunoperoxidase study of renal cell carcinomas: correlation with nuclear grade, cell type, and histologic pattern |
| Q31119899 | Analysis of Fas gene mutations on laser capture microdissected specimens from renal cell carcinoma |
| Q47604279 | Analysis of the prognostic implications of different tumour margin types in renal cell carcinoma |
| Q31126032 | Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma |
| Q84380043 | Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors |
| Q34363440 | Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma? |
| Q80172826 | Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability? |
| Q39961927 | Application of cryobiopsy to morphological and immunohistochemical analyses of xenografted human lung cancer tissues and functional blood vessels |
| Q46291052 | Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma |
| Q42363905 | Assessment of cell proliferation in renal cell carcinoma using dual-phase (18)F-fluorodeoxyglucose PET/CT |
| Q34766784 | Assessment of intratumoral micromorphology for patients with clear cell renal cell carcinoma using susceptibility-weighted imaging |
| Q92366525 | Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor |
| Q34436020 | Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma |
| Q60587582 | Association of 3′ nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population |
| Q34077500 | Automated grading of renal cell carcinoma using whole slide imaging |
| Q34280223 | BAP1 loss defines a new class of renal cell carcinoma |
| Q40001312 | BMI-1 expression is inversely correlated with the grading of renal clear cell carcinoma |
| Q35995717 | Best Practice No 180. Nephrectomy for renal tumour; dissection guide and dataset |
| Q80296462 | Best of the 2001 AUA Annual Meeting: Highlights of the 2001 Annual Meeting of the American Urological Association June 2-7, 2001, Anaheim, CA |
| Q36546056 | Better survival of renal cell carcinoma in patients with inflammatory bowel disease |
| Q77292526 | Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers |
| Q40287858 | Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique |
| Q80938592 | Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique |
| Q40958442 | Biology of metastasis and its clinical implications: renal-cell cancer |
| Q38184386 | Biomarkers in renal cancer |
| Q30472042 | Breaking through a Plateau in Renal Cell Carcinoma Therapeutics: Development and Incorporation of Biomarkers |
| Q64060174 | C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas |
| Q91750169 | C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma - A data from multi-institutional study in Japan |
| Q84993396 | CA9 as a molecular marker for differential diagnosis of cystic renal tumors |
| Q80051636 | CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy |
| Q63214759 | CD2-associated protein in human urogenital system and in adult kidney tumours |
| Q37427983 | CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior. |
| Q49685735 | CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma |
| Q34393744 | Can mycoplasma-mediated oncogenesis be responsible for formation of conventional renal cell carcinoma? |
| Q43518837 | Can renal oncocytoma be distinguished from chromophobe renal cell carcinoma by the presence of fibrous capsule? |
| Q36204192 | Cancer Characteristics and Current Treatments of Patients with Renal Cell Carcinoma in Sweden |
| Q48364905 | Cancer-Specific Survival Stratification Derived from Tumor Expression of Tissue Inhibitor of Metalloproteinase-2 in Non-Metastatic Renal Cell Carcinoma. |
| Q34597696 | Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies |
| Q34338079 | Cannabinoid CB1 Receptor Is Downregulated in Clear Cell Renal Cell Carcinoma |
| Q37187360 | Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade |
| Q34094723 | Caveolin 1 protein expression in renal cell carcinoma predicts survival |
| Q36671655 | Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma |
| Q41626040 | Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms |
| Q85013596 | Characterization and outcome of renal cancers ≤ 4cm treated by surgery |
| Q86911827 | Characterization of clear cell renal cell carcinoma by gene expression profiling |
| Q37363872 | Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma |
| Q26772206 | Chinese guidelines on the management of renal cell carcinoma (2015 edition) |
| Q40461131 | Chromophobe Cell Renal Carcinoma: Clinicopathological Features of 50 Cases |
| Q46570230 | Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases. |
| Q35754544 | Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes |
| Q36617374 | Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer |
| Q36713523 | Classical pathology versus molecular pathology in renal cell carcinoma |
| Q37220373 | Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma |
| Q62494194 | Clear Cell Renal Cell Carcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis for Prediction of Fuhrman Nuclear Grade |
| Q35738410 | Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma |
| Q36518757 | Clear cell papillary renal cell carcinoma: a report of 15 cases including three cases of concurrent other-type renal cell carcinomas |
| Q98159140 | Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment |
| Q37221772 | Clinical Significance of Preoperative Neutrophil - to - Lymphocyte Ratio in Renal Cell Carcinoma |
| Q43806776 | Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma. |
| Q51061127 | Clinical and prognostic value of the presence of irregular giant nuclear cells in pT1 ovarian clear cell carcinoma. |
| Q40443803 | Clinical aspects of renal tumors |
| Q34607538 | Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis |
| Q43743064 | Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma |
| Q48129111 | Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma. |
| Q41055563 | Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma |
| Q40857061 | Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma |
| Q35682006 | Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems. |
| Q35169825 | Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer |
| Q81725970 | Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma |
| Q37127003 | Clinicopathologic features of renal cell carcinoma in young adults: a comparison study with renal cell carcinoma in older patients |
| Q35859957 | Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014. |
| Q35164815 | Clinicopathological features of Xp11.2 translocation renal cell carcinoma |
| Q64282668 | Collagen organization of renal cell carcinoma differs between low and high grade tumors |
| Q42705608 | Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma |
| Q36494196 | Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma. |
| Q36014320 | Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma. |
| Q64117569 | Compare Fuhrman Nuclear and Chromophobe Tumor Grade on Chromophobe RCC |
| Q47561635 | Comparison of RENAL, PADUA, and C-index scoring systems in predicting perioperative outcomes after nephron sparing surgery. |
| Q36292829 | Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma |
| Q77575700 | Comparison of grading systems for estimating the prognosis of renal cell carcinoma |
| Q42674714 | Comparison of laparoscopic radical nephrectomy and open radical nephrectomy for pathologic stage T1 and T2 renal cell carcinoma with clear cell histologic features: a multi-institutional study |
| Q36059885 | Comparison of the Width of Peritumoral Surgical Margin in Open and Robotic Partial Nephrectomy: A Propensity Score Matched Analysis. |
| Q49479344 | Comparisons of oncological outcomes and perioperative complications between laparoscopic and open radical nephrectomies in patients with clinical T2 renal cell carcinoma (≥7cm). |
| Q34206196 | Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer |
| Q35005701 | Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis |
| Q36059910 | Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma. |
| Q52012198 | Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. |
| Q73254713 | Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence |
| Q38356065 | Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma |
| Q42427374 | Correlation of percentage changes in platelet counts with recurrence rate following radical nephrectomy. |
| Q71869775 | Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas |
| Q39148397 | Critical role of TRPC6 channels in the development of human renal cell carcinoma |
| Q44917659 | Cumulative number of altered biomarkers in mammalian target of rapamycin pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma |
| Q37153013 | Current insights in renal cell cancer pathology |
| Q35210978 | Current staging of renal cell carcinoma |
| Q33659189 | Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma |
| Q36343530 | Cyclooxygenase-2 expression and its prognostic significance in clear cell renal cell carcinoma. |
| Q81360558 | Cyclooxygenase-2 expression: does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma? |
| Q34517786 | Cystic renal cell carcinoma: a report of 67 cases including 4 cases with concurrent renal cell carcinoma |
| Q35909342 | Cystic renal cell carcinoma: biology and clinical behavior |
| Q71511262 | Cystic renal masses: a reevaluation of the usefulness of the Bosniak classification system |
| Q41975628 | Cytodiagnosis of myxoid adrenocortical carcinoma and role of immunocytochemistry to differentiate it from renal cell carcinoma |
| Q71556938 | Cytogenetic findings in renal cell carcinoma |
| Q47376963 | Cytohistological study of clear cell carcinoma of kidney with special reference to nuclear grading and tumor size |
| Q35159146 | Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients' survival |
| Q37566643 | Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience |
| Q72642706 | DNA image cytometric analysis of paraffin-embedded sections of small renal cortical neoplasms |
| Q60908659 | DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma |
| Q40937833 | DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC). |
| Q74748701 | DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival |
| Q44758895 | De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients |
| Q43598363 | Decision curve analysis and external validation of the postoperative Karakiewicz nomogram for renal cell carcinoma based on a large single-center study cohort |
| Q36897759 | Decoy receptor 3 is a prognostic factor in renal cell cancer |
| Q46440610 | Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma |
| Q41143296 | Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma |
| Q34250582 | Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma |
| Q46208481 | Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma |
| Q34427294 | Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma |
| Q37191063 | Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis |
| Q82562294 | Designing clinical trials for kidney cancer based on newly developed prognostic and predictive tools |
| Q35050514 | Detection of intratumoral susceptibility signals using T2*-weighted gradient echo MRI in patients with clear cell renal cell carcinoma |
| Q89934293 | Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma |
| Q33573577 | Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinoma |
| Q38616316 | Development and Testing of an LED-Based Near-Infrared Sensor for Human Kidney Tumor Diagnostics. |
| Q58603535 | Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma |
| Q73012242 | Diagnosis and classification of renal cell carcinoma |
| Q37784436 | Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases |
| Q57134936 | Diagnostic accuracy of image-guided biopsies in small (<4 cm) renal masses with implications for active surveillance: a systematic review of the evidence |
| Q36825633 | Diagnostic accuracy of pre-operative imaging findings in presumed clinical T1a renal cell carcinomas |
| Q55007293 | Diagnostic algorithm, prognostic factors and surgical treatment of metastatic cancer diseases of the long bones and spine. |
| Q35155653 | Diagnostic approach to eosinophilic renal neoplasms |
| Q57425968 | Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study |
| Q36261772 | Differences in peritumoral pseudocapsule characteristics according to clinicopathological factors in clinical T1a renal tumors |
| Q81340018 | Differences in presentation characteristics of renal cell carcinoma in the last 25 years: a single center experience |
| Q36132720 | Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma |
| Q47177700 | Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression |
| Q28486028 | Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome |
| Q38482194 | Disease-specific Survival in Patients with Renal Cell Carcinoma: An Audit of a Large Series from Korea |
| Q87014664 | Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases |
| Q44216237 | Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series |
| Q52640027 | Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study. |
| Q36034954 | Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications. |
| Q34106752 | Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma |
| Q40083285 | Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma |
| Q91958409 | Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients with Resected, Localized Clear Cell Renal Cell Carcinoma |
| Q36012470 | EGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinoma. |
| Q37097921 | EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas |
| Q36589287 | Effect of utilization of veno-venous bypass vs. cardiopulmonary bypass on complications for high level inferior vena cava tumor thrombectomy and concomitant radical nephrectomy. |
| Q42726487 | Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts |
| Q27852038 | Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation |
| Q44502912 | Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. |
| Q72011819 | Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors |
| Q53229536 | Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy. |
| Q47855049 | Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer |
| Q37595654 | Epidemiology and staging of renal cell carcinoma |
| Q73914323 | Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma |
| Q43407740 | Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma |
| Q36594107 | Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma |
| Q34979867 | Esophageal metastasis of renal cancer 10 years after nephrectomy |
| Q36045807 | Establishment and characterization of a highly immunogenic human renal carcinoma cell line |
| Q41721643 | Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma |
| Q37967420 | Evaluation and management of small renal masses: looking beyond the tumor margin |
| Q41848027 | Evaluation of a protocol for examining nephrectomy specimens with renal cell carcinoma |
| Q79409152 | Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer |
| Q81217887 | Evaluation of imaging-guided fine-needle percutaneous biopsy of renal masses |
| Q38264178 | Evaluation of oxidative stress status and antioxidant capacity in patients with renal cell carcinoma |
| Q88104755 | Evaluation of renal cell carcinoma histological subtype and fuhrman grade using 18F-fluorodeoxyglucose-positron emission tomography/computed tomography |
| Q36369283 | Expectant management for the treatment of small renal masses |
| Q41410574 | Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients. |
| Q33575499 | Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent |
| Q34443684 | Expression and significance of histone H3K27 demethylases in renal cell carcinoma |
| Q35746324 | Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma |
| Q38501547 | Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance |
| Q53384671 | Expression of CD44 protein in renal cell carcinomas: association with p53 expression. |
| Q36791761 | Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significance |
| Q35653981 | Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival |
| Q90705904 | Expression of CREPT is associated with poor prognosis of patients with renal cell carcinoma |
| Q44604732 | Expression of DNA topoisomerase I in neoplasms of the kidney: correlation with histological grade, proliferation, and patient survival |
| Q73467027 | Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene |
| Q79347797 | Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases |
| Q79249861 | Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth |
| Q47947812 | Expression of Telomere Binding Proteins (RAP1 and POT1) in Renal Cell Carcinoma and Their Correlation with Clinicopathological Parameters |
| Q80509713 | Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome |
| Q80903145 | Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study |
| Q77811308 | Expression of bcl-2, bcl-x, bax and bak in renal parenchyma, oncocytomas and renal cell carcinomas |
| Q36784872 | Expression of claudin-7 in benign kidney and kidney tumors |
| Q36502721 | Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma |
| Q35807891 | Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma |
| Q38491062 | Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation |
| Q37048923 | Expression of insulin-like growth factor family genes in clear cell renal cell carcinoma |
| Q81927331 | Expression of osteopontin and CD44 molecule in papillary renal cell tumors |
| Q79707617 | Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome |
| Q74493841 | Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance |
| Q37212706 | Expression of the interleukin 6 receptor in primary renal cell carcinoma |
| Q36544441 | Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma |
| Q73853975 | Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression |
| Q38494422 | External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma |
| Q41881543 | External validation of the modified Glasgow prognostic score for renal cancer |
| Q52569194 | Extracellular matrix alterations in conventional renal cell carcinomas by tissue microarray profiling influenced by the persistent, long-term, low-dose ionizing radiation exposure in humans. |
| Q91739012 | FORCE dual-energy CT in pathological grading of clear cell renal cell carcinoma |
| Q55040622 | Factors associated with postoperative renal sinus invasion and perinephric fat invasion in renal cell cancer: treatment planning implications. |
| Q39187777 | Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma |
| Q33699348 | Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer |
| Q35995297 | Fibronectin 1 protein expression in clear cell renal cell carcinoma |
| Q56526565 | Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour |
| Q77316019 | Fine needle aspiration cytology of the kidney, renal pelvis, and adrenal |
| Q70623527 | Fine-needle aspiration cytology of sarcomatoid renal cell carcinoma: a morphologic and immunocytochemical study of 15 cases |
| Q33820001 | Fine-needle aspiration of renal cell carcinoma: is accurate Fuhrman grading possible on cytologic material? |
| Q35856053 | Flow cytometric DNA analysis of parathyroid glands. Relationship between nuclear DNA and pathologic classifications. |
| Q77585393 | Flow cytometric and quantitative image cell analysis of DNA ploidy in renal chromophobe cell carcinoma |
| Q71394601 | Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma |
| Q38081379 | Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer |
| Q44461958 | Fuhrman grade [corrected] has no added value in prediction of mortality after partial or [corrected] radical nephrectomy for chromophobe renal cell carcinoma patients |
| Q37437381 | GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression |
| Q46228867 | Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma |
| Q33631354 | Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma |
| Q86561539 | Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database |
| Q92810047 | Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers |
| Q38124228 | Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma |
| Q34698991 | Gene-expression signatures can distinguish gastric cancer grades and stages |
| Q92510722 | Genetic risk classifier to predict localised renal cell carcinoma recurrence |
| Q37090440 | Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome |
| Q50105512 | Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma |
| Q77656018 | Glassy hyaline globules in granular cell carcinoma, chromophobe cell carcinoma, and oncocytoma of the kidney |
| Q37210707 | Grade-dependent proteomics characterization of kidney cancer |
| Q34330627 | Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescents: a comparison of parameters used for the Fédération Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems |
| Q33736873 | Grading of renal cell carcinoma |
| Q37269354 | Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma |
| Q51173342 | Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention. |
| Q43703262 | HSV-tk gene therapy for human renal cell carcinoma in nude mice |
| Q44405105 | High Jagged1 Expression Predicts Poor Outcome in Clear Cell Renal Cell Carcinoma |
| Q64075768 | High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma |
| Q50056562 | High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma |
| Q36611725 | High expression of FER tyrosine kinase predicts poor prognosis in clear cell renal cell carcinoma |
| Q35180050 | High expression of pituitary tumor-transforming gene-1 predicts poor prognosis in clear cell renal cell carcinoma |
| Q41742923 | High peritumoral Bmi-1 expression is an independent prognosticator of poor prognosis in renal cell carcinoma |
| Q87595400 | High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer |
| Q36121660 | High-level expression of stem cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis |
| Q37148917 | Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma |
| Q40232486 | Histologic disorderliness in the arrangement of tumor cells as an objective measure of tumor differentiation |
| Q24658263 | Histological reclassification, histochemical characterization and c-kit immunoexpression in renal cell carcinoma |
| Q53635791 | Histone mRNA in situ hybridization and Ki 67 immunohistochemistry in pediatric adrenocortical tumors. |
| Q88322291 | Histopathologic analysis of tumor bed and peritumoral pseudocapsule after in vitro tumor enucleation on radical nephrectomy specimen for clinical T1b renal cell carcinoma |
| Q40270889 | Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies. |
| Q37197852 | Histopathological analysis of T1 renal cell carcinoma: Does presentation matter? |
| Q45242643 | Histopathology of surgically treated renal tumours in young adults: a developing country perspective |
| Q37148880 | Hypoxia inducible factor-1alpha correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma |
| Q87193599 | Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma |
| Q33556447 | IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing |
| Q30639243 | IVC Thrombectomy in Renal Cell Carcinoma-Analysis of Out Come Data of 100 Patients and Review of Literature |
| Q40415541 | Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array |
| Q35777081 | Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging |
| Q30406355 | Identification of Protein Markers Specific for Papillary Renal Cell Carcinoma Using Imaging Mass Spectrometry |
| Q41106348 | Imaging in the staging of renal cell carcinoma |
| Q50940862 | Immunodetection of c-met-oncogene's protein product in renal cell neoplasia. |
| Q80273307 | Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma |
| Q93034881 | Immunohistochemical expression of renin is a prognostic factor for recurrence in nonmetastatic renal cell carcinoma |
| Q50283056 | Immunohistochemical study of C-kit expression in subtypes of renal cell carcinoma. |
| Q81362083 | Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma |
| Q35157638 | Immunotherapy for renal cell carcinoma |
| Q37404959 | Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study |
| Q33567647 | Impact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma |
| Q34582028 | Impact of partial nephrectomy on kidney function in patients with renal cell carcinoma |
| Q41933788 | Impact of preoperative thrombocytosis on prognosis after surgical treatment in pathological T1 and T2 renal cell carcinoma: results of a multi-institutional comprehensive study |
| Q37446361 | Impact of robotic partial nephrectomy with and without ischemia on renal functions: experience in 34 cases |
| Q47269113 | Impact of tumor size on the clinical outcomes of patients with Robson State I renal cell carcinoma |
| Q73459486 | Improving accuracy in the grading of renal cell carcinoma by combining the quantitative description of chromatin pattern with the quantitative determination of cell kinetic parameters |
| Q64228331 | Improving the diagnosis of renal masses: can we approach the histological diagnosis to the image? |
| Q58371721 | Inactivation of p16 by CpG hypermethylation in renal cell carcinoma |
| Q73437875 | Incidental detection beyond pathological factors as prognostic predictor of renal cell carcinoma |
| Q73930509 | Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997) |
| Q46386017 | Increased activated Akt expression in renal cell carcinomas and prognosis |
| Q46051632 | Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma |
| Q79195955 | Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma |
| Q35028079 | Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma. |
| Q55035306 | Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma. |
| Q77650366 | Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapy |
| Q40372513 | Influence of Exposure to Chronic Persistent Low-Dose Ionizing Radiation on the Tumor Biology of Clear-Cell Renal-Cell Carcinoma. An Immunohistochemical and Morphometric Study of Angiogenesis and Vascular Related Factors |
| Q36306265 | Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy |
| Q89747608 | Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients |
| Q34948760 | Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells |
| Q50884246 | Inhibition of hTERT expression by MAP kinase inhibitor induces cell death in renal cell carcinoma. |
| Q54178005 | Instability of chromosome 8 as an indicator of aggressive tumor phenotype in pancreatic cancer. |
| Q33822523 | Insulin receptor expression in clear cell renal cell carcinoma and its relation to prognosis |
| Q35918018 | Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p |
| Q90683738 | Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease |
| Q42172605 | Integrin distributions in renal cell carcinomas of various grades of malignancy |
| Q92144740 | Interactions between TGF-β type I receptor and hypoxia-inducible factor-α mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma |
| Q79353329 | Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk |
| Q52950682 | Interobserver and Intraobserver Variability Using the Fuhrman Grading System for Renal Cell Carcinoma |
| Q39704965 | Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma. |
| Q74099329 | Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis |
| Q53061492 | Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma. |
| Q78107596 | Intratumoral heterogeneity of DNA content in renal cell carcinoma and its prognostic significance |
| Q38161397 | Invasion and metastasis of renal cell carcinoma |
| Q38889883 | Invasion of the urinary collecting system is an independent prognostic factor in pT3 renal cell carcinoma |
| Q48100155 | Is there a role for epithelial-mesenchymal transition in adrenocortical tumors? |
| Q37114091 | Is there any potential link among caspase-8, p-p38 MAPK and bcl-2 in clear cell renal cell carcinomas? A comparative immunohistochemical analysis with clinical connotations. |
| Q36920156 | Key clinical issues in renal cancer: a challenge for proteomics |
| Q45060115 | Kidney tumors |
| Q53547969 | Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma. |
| Q36649168 | Laparoscopic partial nephrectomy for incidental stage pT2 or worse tumors |
| Q44367463 | Laparoscopic partial nephrectomy for tumours >4 cm compared with smaller tumours: perioperative results. |
| Q85908360 | Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous |
| Q33725382 | Less invasive treatment option for renal carcinoma with venous tumor thrombus |
| Q34207989 | Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7 |
| Q38444129 | Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma |
| Q89513986 | Limited utility of qPCR-based detection of tumor-specific circulating mRNAs in whole blood from clear cell renal cell carcinoma patients |
| Q30318519 | Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma? |
| Q37054261 | Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma |
| Q56782222 | Liver transplantation utilizing grafts from donors with genitourinary cancer detected prior to liver implantation |
| Q88662206 | Localized chromophobe renal cell carcinoma: preoperative imaging judgment and laparoscopic simple enucleation for treatment |
| Q35630107 | Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience |
| Q51101527 | Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma. |
| Q58371735 | Loss of heterozygosity and methylation of p16 in renal cell carcinoma |
| Q47824241 | Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma. |
| Q36853062 | Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis |
| Q53442919 | Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. |
| Q73204422 | Loss or reduction of Fhit expression in renal neoplasias: correlation with histogenic class |
| Q27851432 | Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma |
| Q48269588 | Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma. |
| Q73886335 | Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin |
| Q74094212 | Low-stage renal carcinoma of the native kidneys in renal transplant recipients |
| Q80761298 | Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry |
| Q38083373 | Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival |
| Q36564705 | Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer. |
| Q42058275 | MET expression in sporadic renal cell carcinomas |
| Q53168509 | Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival. |
| Q38497635 | Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene |
| Q84530172 | Maspin expression in renal cell carcinoma and its correlation with clinicopathologic parameters |
| Q36671135 | Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma |
| Q38493582 | Metachronous metastatic potential of small renal cell carcinoma: dependence on tumor size |
| Q38470495 | Metallothionein expression in renal cancer |
| Q33995387 | Metallothionein gene expression in renal cell carcinoma |
| Q35206797 | Metastatic renal cell carcinoma |
| Q73048375 | Metastatic renal cell carcinoma in a child: 11-year disease-free survival following surgery |
| Q64058312 | Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma |
| Q35621551 | MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs |
| Q37683051 | MicroRNA expression signatures of stage, grade, and progression in clear cell RCC. |
| Q50054069 | MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma |
| Q43184280 | MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma |
| Q53393882 | Microscopic Venous Infiltration As Predictor Of Relapse In Renal Cell Carcinoma |
| Q40005099 | Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study |
| Q53558411 | Microvascular tumor invasion: prognostic significance in low-stage renal cell carcinoma. |
| Q35707564 | Microvessel density and heparanase over-expression in clear cell renal cell cancer: correlations and prognostic significances |
| Q40440742 | Microvessel density in renal cell carcinoma: Lack of prognostic significance |
| Q48443748 | Microvessel density is high in clear-cell renal cell carcinomas of Ukrainian patients exposed to chronic persistent low-dose ionizing radiation after the Chernobyl accident |
| Q37876683 | Misdiagnosis of clear cell renal cell carcinoma |
| Q46856592 | Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade |
| Q39146606 | Modified laparoscopic simple enucleation with single-layer suture technique versus standard laparoscopic partial nephrectomy for treating localized renal cell carcinoma |
| Q30475550 | Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma |
| Q37942072 | Molecular aspects of renal cell carcinoma: a review |
| Q35782667 | Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites |
| Q73254679 | Molecular markers in renal cell carcinoma: not quite ready for "prime time" |
| Q55234953 | Molecular targeted therapies of renal cell carcinoma considering life stage of the patient: Two case reports. |
| Q36082151 | Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learned |
| Q88425681 | Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy |
| Q34553628 | Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up |
| Q80353936 | Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma |
| Q34530994 | Multilayer-omics analysis of renal cell carcinoma, including the whole exome, methylome and transcriptome |
| Q42631208 | Multilocular cystic renal cell carcinoma: an experience of clinical management for 31 cases |
| Q63966799 | Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma |
| Q37708077 | Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade |
| Q97588585 | Multiphoton Microscopic Study of the Renal Cell Carcinoma Pseudocapsule: Implications for Tumour Enucleation |
| Q53234284 | Mutational status of VHL gene and its clinical importance in renal clear cell carcinoma. |
| Q39558514 | Myxoid renal cell carcinoma: histological, immunocytochemical and ultrastructural study |
| Q41658924 | Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features |
| Q47250904 | Nephron-sparing surgery for renal cell carcinoma--is tumor size a suitable parameter for indication? |
| Q35556024 | Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome |
| Q46033252 | Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff. |
| Q33187554 | Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior |
| Q50560816 | Non-functional adrenocortical adenoma: A unique case of combination with myelolipoma and endothelial cysts |
| Q37212130 | Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function. |
| Q99630334 | Novel hematological biomarkers predict survival in renal cell carcinoma patients treated with nephrectomy |
| Q38467569 | Novel somatic mutations in the VHL gene in Swedish archived sporadic renal cell carcinomas |
| Q35346391 | Nuclear features in different grades of epithelial dysplasia in leukoplakia: A computer assisted microscopic study |
| Q42539824 | Nuclear features in oral squamous cell carcinoma: A computer-assisted microscopic study |
| Q68202394 | Nuclear grading of renal cell carcinomas--is morphometry necessary? |
| Q33562921 | Nuclear grading versus Gleason grading in small samples containing prostate cancer: a tissue microarray study |
| Q77787984 | Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma |
| Q44395529 | Nuclear morphometry in prognosis of renal adenocarcinoma |
| Q43837146 | Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma |
| Q90163623 | Observations on Solitary Versus Multiple Isolated Pancreatic Metastases of Renal Cell Carcinoma: Another Indication of a Seed and Soil Mechanism? |
| Q38876862 | Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically. |
| Q53097140 | Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy. |
| Q86493392 | Onconeuronal antigen Cdr2 correlates with HIF prolyl-4-hydroxylase PHD1 and worse prognosis in renal cell carcinoma |
| Q87937106 | Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma |
| Q33692617 | Open partial nephrectomy for entirely intraparenchymal tumors: a matched case-control study of oncologic outcome and complication rate |
| Q45849222 | Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: a matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project). |
| Q42612077 | Open versus robotic-assisted partial nephrectomy: a multicenter comparison study of perioperative results and complications |
| Q42596111 | Operative safety and oncologic outcome of laparoscopic radical nephrectomy for renal cell carcinoma >7 cm: a multicenter study of 222 patients. |
| Q37520452 | Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer |
| Q83392188 | Optimal surgical margin in nephron-sparing surgery for T1b renal cell carcinoma |
| Q36859838 | Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell Carcinoma |
| Q38627636 | Organ Preservation is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma - Results of a Comprehensive Multicenter Study |
| Q33951738 | Outcome of surgery in cystic renal cell carcinoma |
| Q55177214 | Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy. |
| Q35137998 | Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinoma and their inhibition by using SiRNA induce apoptosis, reduce cell proliferation and migration invitro |
| Q55347723 | Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells in vitro. |
| Q64256545 | Overexpression of BHLHE41, correlated with DNA hypomethylation in 3'UTR region, promotes the growth of human clear cell renal cell carcinoma |
| Q35995303 | Overexpression of IL-32 is a novel prognostic factor in patients with localized clear cell renal cell carcinoma |
| Q39395530 | Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells |
| Q47724348 | Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma |
| Q92338520 | PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients |
| Q38899769 | PD-1/PD-L1 blockade in renal cell cancer |
| Q39329024 | PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception? |
| Q38869627 | PD-L2: A prognostic marker in chromophobe renal cell carcinoma? |
| Q36063180 | PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression |
| Q64910634 | PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis. |
| Q87756682 | Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations |
| Q47988158 | Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases |
| Q50895779 | Paraneoplastic hormones: parathyroid hormone-related protein (PTHrP) and erythropoietin (EPO) are related to vascular endothelial growth factor (VEGF) expression in clear cell renal cell carcinoma. |
| Q45243353 | Paraneoplastic symptoms: cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma |
| Q40131069 | Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project). |
| Q37149479 | Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors. |
| Q57290130 | Parvalbumin Is Constantly Expressed in Chromophobe Renal Carcinoma |
| Q38447341 | Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival. |
| Q47140372 | Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens |
| Q84420943 | Pathologic significance and prognostic value of phosphorylated cortactin expression in patients with sarcomatoid renal cell carcinoma |
| Q44152842 | Pathological characteristics and prognostic effect of peritumoral capsule penetration in renal cell carcinoma after tumor enucleation |
| Q43287172 | Pathological nature of renal tumors - does size matter? |
| Q89430085 | Patterns of management of translocation renal cell carcinoma |
| Q40772952 | Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas |
| Q37165416 | Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma. |
| Q51582736 | Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade. |
| Q84587291 | Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma |
| Q47879190 | Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinoma |
| Q38696613 | Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis |
| Q36250674 | Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma |
| Q52585312 | Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin. |
| Q38498464 | Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma |
| Q77656069 | Pigmented microcystic chromophobe cell carcinoma: a unique variant of renal cell carcinoma |
| Q35741847 | Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas |
| Q69217784 | Placental-like alkaline phosphatase reactivity in human tumors: an immunohistochemical study of 520 cases |
| Q37040588 | Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas. |
| Q30457801 | Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era. |
| Q36954320 | Port-site metastasis as a primary complication following retroperitoneal laparoscopic radical resection of renal pelvis carcinoma or nephron-sparing surgery: A report of three cases and review of the literature |
| Q49715374 | Positive surgical margins are predictors of local recurrence in conservative kidney surgery for pT1 tumors |
| Q30424590 | Post-nephrectomy foreign-body granuloma in the retroperitoneum mimicking lymph node metastasis of renal cell cancer |
| Q33655475 | Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy |
| Q51704190 | Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. |
| Q38094918 | Potential biofluid markers and treatment targets for renal cell carcinoma |
| Q40812617 | Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients |
| Q50971850 | Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study. |
| Q35738214 | Predicting factors for death from other causes in patients with localized renal cell carcinoma |
| Q35962326 | Predicting length of stay after robotic partial nephrectomy |
| Q82506977 | Predicting pulmonary adenocarcinoma outcome based on a cytology grading system |
| Q64227714 | Prediction of ISUP grading of clear cell renal cell carcinoma using support vector machine model based on CT images |
| Q35016114 | Prediction of clear cell renal cell carcinoma by integrity of cell-free DNA in serum |
| Q90132130 | Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era |
| Q60309948 | Predictive value of preoperative monocyte-lymphocyte ratio among patients with localized clear renal cell carcinoma of ≤7 cm on preoperative imaging |
| Q93185517 | Predictive value of preoperative neutrophil-to-lymphocyte ratio in non-metastatic papillary renal cell carcinoma patients after receiving curative surgery |
| Q53372454 | Premalignant lesions of the kidney share the same genetics changes as conventional renal cell carcinoma. |
| Q37667797 | Preoperative Albumin to Globulin Ratio (AGR) as Prognostic Factor in Renal Cell Carcinoma |
| Q43644114 | Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma |
| Q36148206 | Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy |
| Q36070506 | Preoperative Neutrophil-to-Lymphocyte Ratio and Neutrophilia Are Independent Predictors of Recurrence in Patients with Localized Papillary Renal Cell Carcinoma |
| Q37624146 | Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment |
| Q41471582 | Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients |
| Q33730215 | Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy |
| Q38259002 | Preoperative cross-sectional imaging allows for avoidance of unnecessary adrenalectomy during RCC surgery |
| Q36961767 | Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT. |
| Q33769101 | Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma. |
| Q24813050 | Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study |
| Q35720587 | Primary care update on kidney and bladder cancer: a urologic perspective |
| Q34579979 | Primary renal tumours in cats: 19 cases (1992-1998). |
| Q98771284 | Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas |
| Q33646077 | Prognostic Value of Vascular Endothelial Growth Factor A in the Prediction of the Tumor Aggressiveness in Clear Cell Renal Cell Carcinoma |
| Q34574526 | Prognostic ability of simplified nuclear grading of renal cell carcinoma |
| Q91998697 | Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma |
| Q88142151 | Prognostic and Predictive Factors for Renal Cell Carcinoma |
| Q88527533 | Prognostic factors and prognostic models for renal cell carcinoma: a literature review |
| Q74325662 | Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases |
| Q35210976 | Prognostic factors in renal cell carcinoma |
| Q83987586 | Prognostic factors in renal cell carcinoma |
| Q48971310 | Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients |
| Q77856861 | Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy |
| Q64271721 | Prognostic impact of tumor-infiltrating CD276/Foxp3-positive lymphocytes and associated circulating cytokines in patients undergoing radical nephrectomy for localized renal cell carcinoma |
| Q34995476 | Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis |
| Q36963971 | Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study |
| Q78638940 | Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma |
| Q47192438 | Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters |
| Q52205094 | Prognostic index of renal carcinomas. |
| Q35588266 | Prognostic relevance of extensive necrosis in renal cell carcinoma |
| Q38794945 | Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens |
| Q79917291 | Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases |
| Q36375196 | Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma |
| Q46407811 | Prognostic role of global DNA-methylation and histone acetylation in pT1a clear cell renal carcinoma in partial nephrectomy specimens. |
| Q88662213 | Prognostic role of preoperative albumin to globulin ratio in predicting survival of clear cell renal cell carcinoma |
| Q35527136 | Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma |
| Q38610950 | Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients |
| Q43595796 | Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era. |
| Q33758236 | Prognostic significance of grading in lung adenocarcinoma |
| Q24791792 | Prognostic significance of metallothionein expression in renal cell carcinoma |
| Q36178160 | Prognostic significance of perirenal infiltration in renal cell carcinoma (<7 cm) |
| Q41542807 | Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma |
| Q34609822 | Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma |
| Q90480428 | Prognostic significance of the sub-classification of stage pT3a renal tumors by perinephric and sinus fat invasion |
| Q38947146 | Prognostic tissue biomarker exploration for patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors |
| Q38357713 | Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort |
| Q35060552 | Prognostic value of EZH2 expression and activity in renal cell carcinoma: a prospective study |
| Q89283007 | Prognostic value of UTX expression in patients with clear cell renal cell carcinoma |
| Q41592612 | Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model |
| Q47157452 | Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma |
| Q74599846 | Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma. Long-term analysis in 213 patients |
| Q95797120 | Prognostic value of nuclear morphometry in patients with TNM stage T1 ovarian clear cell adenocarcinoma |
| Q86569733 | Prognostic value of preoperative lymphocyte to monocyte ratio in patients with nonmetastatic clear cell renal cell carcinoma |
| Q47379122 | Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma |
| Q34438914 | Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes |
| Q63634051 | Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7 |
| Q44070437 | Proliferative cell index in endometrial adenocarcinoma of different nuclear grades |
| Q36182156 | Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome |
| Q81318606 | Proposal for revision of the TNM classification system for renal cell carcinoma |
| Q60960769 | Prospective Evaluation of Unprocessed Core Needle Biopsy DNA and RNA Yield from Lung, Liver, and Kidney Tumors: Implications for Cancer Genomics |
| Q73499752 | Prospective evaluation of fine needle aspiration of small, solid renal masses: Accuracy and morbidity |
| Q39387572 | Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner |
| Q37676786 | Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma |
| Q35150432 | Proteomics approaches for identification of tumor relevant protein targets in pulmonary squamous cell carcinoma by 2D-DIGE-MS. |
| Q45406058 | Quality of pathological reporting for renal cell cancer: implications for systemic therapy, prognostication and surveillance |
| Q36247210 | Quantitative Light Microscopy in Urological Oncology |
| Q78136573 | Quantitative image cell analysis of cytologic smears for DNA ploidy in renal parenchymal neoplasms |
| Q33291459 | Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors |
| Q92307015 | RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma |
| Q46550072 | Racial disparity in incidence patterns and outcome of kidney cancer |
| Q37579054 | Radical or simple nephrectomy in localized renal cell carcinoma: what is a choice? |
| Q91253715 | Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma |
| Q42575103 | Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference? |
| Q71791416 | Recommendations for the reporting of resected neoplasms of the kidney. Association of Directors of Anatomical and Surgical Pathology |
| Q40333846 | Recurrence pattern in patients with locally advanced renal cell carcinoma: The implications of clinicopathological variables. |
| Q35150993 | Relating prognosis in chromophobe renal cell carcinoma to the chromophobe tumor grading system. |
| Q74107731 | Relationship between flow cytometric DNA ploidy and nuclear grade with endocrine dysfunction in adrenal cortical adenomas |
| Q28386222 | Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors |
| Q38113553 | Relevance of microscopic indicators of chromosomal instability in routine reporting of malignancies |
| Q90446768 | Renal Cell Carcinoma Follow-Up - Is it Time to Abandon Ultrasound? |
| Q38665919 | Renal Cell Carcinoma in Kidney Transplant Candidates. |
| Q35964825 | Renal Tumours in Adults with Correlation between Fuhrman Grading and Proliferative Marker. |
| Q77505180 | Renal adenocarcinoma with tumour thrombi in the inferior vena cava and right atrium in a pedestrian motor vehicle accident fatality: case report and medicolegal implications |
| Q81273634 | Renal artery changes in patients with primary renal cell carcinoma |
| Q34984201 | Renal cancer: cytogenetic and molecular genetic aspects |
| Q30235364 | Renal cell carcinoma |
| Q56019530 | Renal cell carcinoma |
| Q73669457 | Renal cell carcinoma |
| Q35029720 | Renal cell carcinoma in India demonstrates early age of onset & a late stage of presentation |
| Q71082501 | Renal cell carcinoma in childhood and adolescence: a retrospective survey for prognostic factors in 22 cases |
| Q67679793 | Renal cell carcinoma in children: Histology, immunohistochemistry, and follow-up of 10 cases |
| Q72716177 | Renal cell carcinoma in the presence of adult polycystic kidney disease |
| Q71576088 | Renal cell carcinoma metastatic to the gallbladder or prostate: two case reports |
| Q35178022 | Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature |
| Q40022143 | Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. |
| Q46841489 | Renal cell carcinoma with inferior vena cava thrombus: the Hacettepe experience |
| Q68215745 | Renal cell carcinoma: Comparison of morphological and flow cytometric parameters of primary tumour and invasive tumour lying within the renal vein |
| Q34081741 | Renal cell carcinoma: diagnosis and treatment, 1994-2003. |
| Q35559860 | Renal cell carcinoma: new prognostic factors? |
| Q37321213 | Renal cell carcinoma: risk assessment and prognostic factors for newly diagnosed patients |
| Q42516408 | Renal collecting duct carcinoma in an 8-year-old child |
| Q36935404 | Reproducibility and reliability of tumor grading in urological neoplasms |
| Q44547670 | Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life |
| Q67967022 | Retroperitoneal fibrosis as host response to papillary renal cell carcinoma |
| Q47096248 | Rho GDP dissociation inhibitor-β in renal cell carcinoma |
| Q37185851 | Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma |
| Q64113864 | Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers |
| Q33736877 | Risk and prognosis in renal neoplasms. A pathologist's prospective |
| Q36737011 | Risk factors, classification, and staging of renal cell cancer |
| Q40656902 | Risk of metastasis for T1a renal cell carcinoma |
| Q37130158 | Risk stratification and prognostication of renal cell carcinoma |
| Q42667327 | Robot-assisted partial nephrectomy for renal tumors larger than 4 cm: results of a multicenter, international series. |
| Q42630053 | Robotic vs open simple enucleation for the treatment of T1a-T1b renal cell carcinoma: a single center matched-pair comparison |
| Q37812611 | Role of C-reactive protein as a biomarker for renal cell carcinoma |
| Q81687859 | Role of KIT expression in the prognosis of clear cell renal cell carcinomas in Chinese patients |
| Q43938053 | Role of low nuclear grading of renal carcinoma cells in the functional profile of tumor-infiltrating T cells |
| Q36272352 | Role of molecular markers in the diagnosis and therapy of renal cell carcinoma. |
| Q30940211 | Role of open nephron sparing surgery in the era of minimal invasive surgery |
| Q50148430 | Sarcomatoid renal cell carcinoma: Biology and treatment advances |
| Q46078457 | Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials |
| Q44012124 | Screening for acquired cystic kidney disease: a decision analytic perspective |
| Q84882229 | Searching for Hif1-α interacting proteins in renal cell carcinoma |
| Q37100490 | Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma |
| Q38418037 | Semantic interpretation of robust imaging features for Fuhrman grading of renal carcinoma |
| Q78319854 | Serum angiogenic activity: diagnostic relevance in renal cell carcinoma |
| Q54578238 | Serum cell-free DNA in renal cell carcinoma: a diagnostic and prognostic marker. |
| Q34995745 | Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma |
| Q45836927 | Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma |
| Q53362473 | Significance of COX-2 expression in human renal cell carcinoma. |
| Q53357652 | Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma. |
| Q74598663 | Significance of angiogenesis and microvascular invasion in renal cell carcinoma |
| Q80534129 | Significance of heat shock protein-27 expression in patients with renal cell carcinoma |
| Q38492372 | Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: a comparison with conventional renal cell carcinoma |
| Q80485496 | Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma |
| Q37001784 | Simultaneous metastases of clear cell renal cell carcinoma to the urinary bladder and left retroperitoneal space: A case report and review of the literature |
| Q33557492 | Single minimum incision endoscopic radical nephrectomy for renal tumors with preoperative virtual navigation using 3D-CT volume-rendering |
| Q34618828 | Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma |
| Q36163659 | Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas |
| Q47331603 | Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma |
| Q33828156 | Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinoma. |
| Q46274174 | Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival |
| Q35948243 | Snail heterogeneity in clear cell renal cell carcinoma. |
| Q73401237 | Soluble Fas in serum from patients with renal cell carcinoma |
| Q33579266 | Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients |
| Q33961565 | Stage-related alterations in renal cell carcinoma--comprehensive quantitative analysis by 2D-DIGE and protein network analysis |
| Q35573946 | Staging Renal Cell Carcinoma With Helical CT: The Revised 1997 AJCC and UICC TNM Criteria |
| Q43196135 | Stauffer's syndrome as a prominent manifestation of renal cancer: a case report |
| Q39295791 | Sternal metastasis as an initial presentation of renal cell carcinoma: a case report |
| Q36367103 | Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis |
| Q40396846 | Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor |
| Q42316344 | Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival |
| Q80274700 | Strong significant correlation between MMP-9 and systemic symptoms in patients with localized renal cell carcinoma |
| Q73727617 | Successful grading of renal-cell carcinoma in fine-needle aspirates |
| Q39012351 | Supremacy of modern morphometry in typing renal oncocytoma and malignant look-alikes |
| Q50014545 | Surgical resection of locally recurrent renal cell carcinoma after nephrectomy: Oncological outcome and predictors of survival |
| Q92625843 | Surgical treatment for renal masses in the elderly: analysis of oncological, surgical and functional outcomes |
| Q35609578 | Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease |
| Q79715050 | Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification |
| Q48317645 | Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era. |
| Q35856558 | Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma: genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression |
| Q47129616 | Synergy Effect of Combining Fluorescence and Mid Infrared Fiber Spectroscopy for Kidney Tumor Diagnostics. |
| Q64092735 | Syntaxin 6: A novel predictive and prognostic biomarker in papillary renal cell carcinoma |
| Q90320986 | Systematic review of ablative therapy for the treatment of renal allograft neoplasms |
| Q29615757 | Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes |
| Q35569322 | Systemic adjuvant therapies in renal cell carcinoma |
| Q36287097 | Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma |
| Q38888527 | TIMP-1 as well as Microvessel Invasion and High Nuclear Grade Is a Significant Determinant Factor for Extension of Tumor Diameter in Localized RCC. |
| Q38767883 | TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma |
| Q36934787 | Targeted therapies for kidney cancer in urologic practice |
| Q33619046 | Tetravalent antibody-scTRAIL fusion proteins with improved properties |
| Q33786666 | The Application of Internal Suspension Technique in Retroperitoneal Laparoscopic Partial Nephrectomy for Renal Ventral Tumors |
| Q87907118 | The Choi response criteria for inferior vena cava tumor thrombus in renal cell carcinoma treated with targeted therapy |
| Q61811736 | The Expression Patterns of FAM83H and PANX2 Are Associated With Shorter Survival of Clear Cell Renal Cell Carcinoma Patients |
| Q36235826 | The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases |
| Q37331556 | The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis |
| Q91689872 | The History of Urology at the Minneapolis Veterans Affairs Health Care System |
| Q53097603 | The ISUP system of staging, grading and classification of renal cell neoplasia. |
| Q54940590 | The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients' Survival. |
| Q89537507 | The Roles of Ubiquitination Factor E4B (UBE4B) in the Postoperative Prognosis of Patients with Renal Cell Carcinoma and in Renal Tumor Cells Growth and Metastasis |
| Q92297589 | The Utrecht Score: A novel histopathological scoring system to assess the prognosis of dogs with cortisol-secreting adrenocortical tumours |
| Q91272464 | The Vitamin D status is associated with serum C-reactive protein and adhesion molecules in patients with renal cell carcinoma |
| Q40714570 | The WHO/ISUP grading system for renal carcinoma |
| Q37945487 | The Weiss score and beyond--histopathology for adrenocortical carcinoma |
| Q51037310 | The accuracy of renal tumor biopsy: analysis from a national prospective study. |
| Q37632347 | The additional utility of apparent diffusion coefficient values of clear-cell renal cell carcinoma for predicting metastasis during clinical staging. |
| Q90673284 | The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma |
| Q40562392 | The clinical and biological significance of MICA in clear cell renal cell carcinoma patients |
| Q44184293 | The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice |
| Q47150674 | The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma |
| Q38478491 | The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma |
| Q37643154 | The current role of renal biopsy in the management of localized renal tumors |
| Q90274546 | The current status of renal cell carcinoma and prostate carcinoma grading |
| Q50050970 | The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma |
| Q89687409 | The effect of antioxidant status on overall survival in renal cell carcinoma |
| Q35344603 | The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma |
| Q86033585 | The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma |
| Q36643660 | The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma |
| Q43985087 | The frequency of tumor-infiltrating Tie-2-expressing monocytes in renal cell carcinoma: its relationship to angiogenesis and progression |
| Q36234181 | The growth rate of "clinically significant" renal cancer |
| Q97067335 | The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma |
| Q84042816 | The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma |
| Q36274270 | The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox". |
| Q35396328 | The importance of IL-6 protein expression in primary human renal cell carcinoma: an immunohistochemical study |
| Q81029090 | The importance of histology and cytogenetics in decision making for renal cell carcinoma |
| Q44492703 | The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis |
| Q36612383 | The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer |
| Q88937572 | The loss of BAP1 protein expression predicts poor prognosis in patients with nonmetastatic clear cell renal cell carcinoma with inferior vena cava tumor thrombosis |
| Q36735738 | The mutationally activated Met receptor mediates motility and metastasis |
| Q40443811 | The pathology of renal tumors |
| Q64104764 | The potential role of miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell carcinoma |
| Q46026293 | The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma. |
| Q97595748 | The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy |
| Q36784093 | The prognostic utility of preoperative neutrophil-to-lymphocyte ratio in localized clear cell renal cell carcinoma |
| Q50752830 | The prognostic value of cyclin D1 in renal cell carcinoma. |
| Q33847917 | The relationship between human leukocyte antigens (HLA) and renal cell carcinoma |
| Q35551037 | The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer |
| Q34328412 | The role of resection for patients with renal carcinoma |
| Q92433428 | The safety and validity of surgical resection for hemodialysis-dependent patients with renal cell carcinomas involving the inferior vena cava |
| Q51767200 | The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma. |
| Q42650622 | The use of partial nephrectomy: results from a contemporary national prospective multicenter study |
| Q36982059 | Tissue-based research in kidney cancer: current challenges and future directions |
| Q37392608 | Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma |
| Q35170748 | Transglutaminase 2 expression and its prognostic significance in clear cell renal cell carcinoma |
| Q24685938 | Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1 |
| Q64099085 | Trends in clinical, operative, and pathologic characteristics of surgically treated renal mass in a Korean center: A surgical series from 1988 through 2015 |
| Q51327165 | Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma. |
| Q43739592 | Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma |
| Q35210973 | Tumor antigens and markers in renal cell carcinoma |
| Q39549735 | Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins |
| Q34365572 | Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma |
| Q43190566 | Tumor grade of clear cell renal cell carcinoma assessed by contrast-enhanced computed tomography |
| Q37269232 | Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma |
| Q34033309 | Tumor necrosis factor receptor expression and signaling in renal cell carcinoma |
| Q47322509 | Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma |
| Q38894640 | Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2. |
| Q34289618 | Tumor thrombus of inferior vena cava in patients with renal cell carcinoma - clinical and oncological outcome of 50 patients after surgery |
| Q36865032 | Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma |
| Q37681761 | Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma |
| Q33560238 | Tumors of the kidney, ureter, and bladder |
| Q33762745 | Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy |
| Q37734791 | Ubiquitin ligase SMURF1 functions as a prognostic marker and promotes growth and metastasis of clear cell renal cell carcinoma |
| Q36860625 | Understanding the natural biology of kidney cancer: implications for targeted cancer therapy. |
| Q34408842 | Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study |
| Q35789042 | Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma |
| Q34758723 | Update on pathologic staging of renal cell carcinoma |
| Q40777374 | Urinary NMP22 and renal cell carcinoma |
| Q45875218 | Urinary collecting system invasion is a predictor for overall and disease-specific survival in locally invasive renal cell carcinoma |
| Q46019991 | Use of the University of California Los Angeles Integrated Staging System (UISS) to predict survival in localized renal cell carcinoma in an Asian population. |
| Q71598643 | Utility of fine-needle aspiration biopsy in solid renal masses |
| Q33307398 | VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma. |
| Q37103768 | VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value |
| Q35332976 | VEGFR-1 Expression Relates to Fuhrman Nuclear Grade of Clear Cell Renal Cell Carcinoma |
| Q55450682 | VHL status regulates transforming growth factor-β signaling pathways in renal cell carcinoma. |
| Q33359761 | Vaginal metastasis and thrombocytopenia from renal cell carcinoma |
| Q53136939 | Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma. |
| Q47261072 | Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population. |
| Q37776821 | Validation of the 2009 TNM Version in a Large Multi-Institutional Cohort of Patients Treated for Renal Cell Carcinoma: Are Further Improvements Needed? |
| Q73591086 | Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma |
| Q78390318 | Value of urinary NMP-22 in patients with renal cell carcinoma |
| Q37248876 | Value of volume weighted mean nuclear volume in grading and prognosis of renal cell carcinoma |
| Q51019551 | Variation in genomic landscape of clear cell renal cell carcinoma across Europe. |
| Q40987120 | Various features and surgical approach of solitary pancreatic metastasis from renal cell carcinoma |
| Q52658572 | Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma. |
| Q53447612 | Volume doubling time and growth rate of renal cell carcinoma determined by helical CT: a single-institution experience. |
| Q87044870 | Volumetric measurement of compensatory hypertrophy in the contralateral normal kidney by the tumor growth |
| Q55110633 | Von Hippel-Lindau Disease. |
| Q44994028 | What is the role of percutaneous needle core biopsy in diagnosis of renal masses? |
| Q54323156 | Which Patients Should We Follow up beyond 5 Years after Definitive Therapy for Localized Renal Cell Carcinoma? |
| Q35074682 | Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma |
| Q93387909 | World Health Organization (WHO)/International Society of Urological Pathology (ISUP) grading in fine-needle aspiration biopsies of renal masses |
| Q38498243 | Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma |
| Q74256072 | [Assessment of the basal membrane status as prognostic factor in renal carcinoma] |
| Q54318661 | [CCAFU Recommendations 2013: Renal cancer]. |
| Q73286400 | [Epidemiologic analysis of clear cell and chromophilic carcinoma of the kidney] |
| Q83912194 | [Evaluation of pT3a stage in the current classification for renal cancer] |
| Q83912191 | [Expression of CD10 and renal cell carcinoma marker in clear cell renal cell carcinoma: analysis on tissue arrays] |
| Q79896569 | [Expression of cytokeratin 5 and calretinin in clear-cell renal cell carcinoma] |
| Q83912199 | [Growing incidence in renal cell carcinoma] |
| Q57647371 | [Incidental renal cancer in young adults: clinical and histopathological findings] |
| Q90376657 | [Noninvasive phenotyping of renal tumors-current state of the art] |
| Q83178941 | [Pathological prognostic indicators in renal cell carcinoma] |
| Q87061371 | [Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database] |
| Q79894721 | [Prognostic factors for disease progression in patients with renal cell carcinoma] |
| Q81519646 | [Prognostic factors in localized and in metastatic renal cell carcinomas] |
| Q84356741 | [Prognostic factors in renal cell carcinoma] |
| Q82728667 | [Recommendations Onco-Urology 2010: Kidney cancer] |
| Q87422849 | [Renal cancer biomarkers. What is justified?] |
| Q81557185 | [Renal cell carcinoma 2008. Histopathology, molecular genetics and new therapeutic options] |
| Q73892042 | [Renal cell carcinoma in adults less than 40 years of age: a particular cancer? Incidence, outcome and review of the literature] |
| Q79743057 | [Renal cell carcinoma. Comparative analysis of the prognostic significance of the WHO-classification and the Störkel's prognostic score] |
| Q87410589 | [WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?] |
| Q83878468 | [Weiss system: a still in-use diagnostic tool for the assessment of adrenocortical malignancy] |
| Q57782612 | hTERT expression in sporadic renal cell carcinomas |
| Q38990071 | hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor |
| Q35590660 | let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma |
| Q47161849 | lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression. |
| Q28305036 | miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma |
| Q55644580 | miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma. |
| Q58753441 | miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma |
| Q42906130 | p-AKT overexpression in primary renal cell carcinomas and their metastases |
| Q38462646 | p53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinoma |
| Q73174805 | p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma |
| Q53714945 | pS6 Expression in normal renal parenchyma, primary renal cell carcinomas and their metastases. |
| Q90039561 | sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro |
| Q86361461 | βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma |
Search more.